Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine (Mixed Salts of a Single-Entity Amphetamine Product) 3.125 mg/1 extended-release capsules are a prescription medication used to treat ADHD and narcolepsy. This extended-release formulation provides controlled delivery of the active ingredients.

Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 is primarily used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. This medication helps improve focus, reduce impulsivity, and manage symptoms associated with these conditions. It is often prescribed when a patient requires a controlled release of the active ingredients throughout the day.

Common effects of Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 may include increased alertness, improved concentration, and reduced fatigue. Some individuals may experience side effects such as decreased appetite, insomnia, or mild gastrointestinal discomfort. The extended-release formulation is designed to minimize peaks and troughs in drug levels.

Handle Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 with care, as it is a controlled substance. Store it in a secure location to prevent misuse. Follow the prescribed dosage and administration instructions provided by your healthcare provider. Avoid sudden discontinuation without medical advice.

Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 may interact with certain medications, including monoamine oxidase inhibitors (MAOIs), antidepressants, and other stimulants. Consuming alcohol while taking this medication is not recommended, as it may increase the risk of side effects. Always inform your healthcare provider of all medications you are taking.